IL22 and colorectal carcinoma: Regarding the role of TH22/IL-22 in CRC, in vitro studies have shown that IL-22 enhances nitric oxide synthase expression in colon cancer cells, significantly contributing to conversion to nitrites, which are associated with colonic inflammation and carcinogenesis (132).